Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Terns Pharmaceuticals (TERN) Accumulated Depreciation & Amortization (2020 - 2022)

Terns Pharmaceuticals' Accumulated Depreciation & Amortization history spans 3 years, with the latest figure at $1.4 million for Q4 2022.

  • For Q4 2022, Accumulated Depreciation & Amortization rose 18.31% year-over-year to $1.4 million; the TTM value through Dec 2022 reached $1.4 million, up 18.31%, while the annual FY2022 figure was $1.4 million, 18.31% up from the prior year.
  • Accumulated Depreciation & Amortization reached $1.4 million in Q4 2022 per TERN's latest filing, up from $1.2 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.4 million in Q4 2022 to a low of $689000.0 in Q4 2020.
  • Average Accumulated Depreciation & Amortization over 3 years is $1.1 million, with a median of $1.2 million recorded in 2021.
  • Peak YoY movement for Accumulated Depreciation & Amortization: soared 71.99% in 2021, then increased 18.31% in 2022.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $689000.0 in 2020, then skyrocketed by 71.99% to $1.2 million in 2021, then grew by 18.31% to $1.4 million in 2022.
  • Per Business Quant, the three most recent readings for TERN's Accumulated Depreciation & Amortization are $1.4 million (Q4 2022), $1.2 million (Q4 2021), and $689000.0 (Q4 2020).